Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2023-09-15 Share Issue/Capital Cha…
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
BIOERA SPA - Comunicazione di variazione del capitale sociale
Share Issue/Capital Change Classification · 1% confidence The document is an official communication from BIOERA SPA, identified by the 'Informazione Regolamentata n. 0771-66-2023' header, typical of regulated market disclosures in Italy (Euronext Milan). The subject ('Oggetto') is 'BIOERA SPA - Comunicazione di variazione del capitale sociale' (Communication of change in share capital). The text details the issuance of new ordinary shares following the conversion of convertible bonds and updates the total number of shares and shareholder structure. This directly relates to changes in the company's capital structure, which aligns with the 'Capital/Financing Update' definition (Code: CAP). Although it involves share issuance, the primary focus is the formal notification of the resulting capital change, making CAP more specific than SHA (Share Issue/Capital Change) which often implies the announcement of the *plan* or *action* itself, whereas this is the formal post-event update required by regulation.
2023-09-15 Italian
BIOERA SPA - Conversione di n. 5 obbligazioni convertibili
Capital/Financing Update Classification · 1% confidence The document is an official communication from BIOERA S.p.A. dated September 5, 2023, detailing the conversion of convertible bonds into new ordinary shares. The subject explicitly mentions the 'Conversione di n. 5 obbligazioni convertibili' (Conversion of 5 convertible bonds) and details the resulting capital increase and the number of new shares issued. This action directly relates to changes in the company's capital structure and financing instruments. This fits the definition of 'Capital/Financing Update' (CAP), as it details the execution of a previously agreed financing arrangement (convertible bond loan) resulting in a capital change. Although it results in a share issue, the primary focus is the conversion mechanism of debt into equity, making CAP more specific than SHA (Share Issue/Capital Change) which is broader.
2023-09-05 Italian
BIOERA SPA - Informativa mensile POC Agosto 2023
Capital/Financing Update Classification · 1% confidence The document is titled "Informativa mensile al 31 agosto 2023" (Monthly Information as of August 31, 2023) and references specific regulatory communications (CONSOB n. 1/23) regarding convertible bonds and capital strengthening operations. It details monthly transactions (subscription and conversion data) related to financing activities. This structure—a periodic report detailing financial/capital structure changes and compliance updates—is characteristic of an Interim/Quarterly Report (IR), especially since it is a monthly update rather than a full annual report (10-K) or just a brief earnings release (ER). Although it discusses capital changes, the primary function here is periodic financial/compliance reporting for a period shorter than a year. It is not a general announcement of a report (RPA) as it contains substantial data.
2023-09-01 Italian
BIOERA SPA - Informativa al mercato ex art. 114 (TUF) al 31/07/2023
Management Reports Classification · 1% confidence The document is an official communication from BIOERA S.p.A. titled "Informativa al mercato ai sensi dell'art. 114, comma 5, D.lgs. n. 58/98 ('TUF')" with a reference period ending 31 July 2023. Article 114(5) of the Italian TUF (Testo Unico della Finanza) mandates the disclosure of specific financial data, such as net financial debt and overdue payables, when requested by the regulator (Consob). This type of periodic, mandatory disclosure of key financial metrics, often triggered by regulatory requests or specific events, fits the description of an Interim/Quarterly Report (IR) or a specific regulatory disclosure. Since it provides detailed financial tables (Net Debt, Overdue Payables) for a period shorter than a year (July 31, 2023), it is best classified as an Interim/Quarterly Report (IR). It is not a full Annual Report (10-K), an Earnings Release (ER, which is usually just highlights), or a general Regulatory Filing (RNS), as it has a specific financial reporting purpose. Note: While it is a regulatory disclosure, the content strongly aligns with the comprehensive nature of an Interim Report (IR) rather than a brief RNS announcement.
2023-08-31 Italian
BIOERA SPA - Conversione di n 3 obbligazioni convertibili
Capital/Financing Update Classification · 1% confidence The document is a formal communication from BIOERA S.p.A. dated August 31, 2023, titled 'Conversione di n. 3 obbligazioni convertibili...' (Conversion of n. 3 convertible bonds...). It details the conversion of convertible bonds into new ordinary shares, specifying the number of bonds, the conversion price (€0.089), and the resulting increase in share capital (337,079 new shares). This action directly relates to changes in the company's capital structure resulting from a financing agreement (convertible bond loan). This fits the definition of 'Capital/Financing Update' (CAP), as it reports on the execution of a financing instrument that alters the capital base. Although it involves shares, it is not a general share issue announcement (SHA) but the result of a specific debt-to-equity conversion.
2023-08-31 Italian
BIOERA SPA - Conversione di n. 2 obbligazioni convertibili
Share Issue/Capital Change Classification · 1% confidence The document is an official communication from BIOERA S.p.A. regarding the conversion of convertible bonds into new ordinary shares. The subject line explicitly mentions 'Conversione di n. 2 obbligazioni convertibili' (Conversion of n. 2 convertible bonds). This action directly relates to changes in the company's capital structure and financing agreements. This fits best under the 'Capital/Financing Update' category (CAP), as it details the execution of a previously agreed-upon financing instrument (convertible bond loan) resulting in a share issuance. Although it involves share issuance (SHA), the primary context is the execution of a financing/debt instrument conversion, making CAP more precise than SHA, which usually covers new primary offerings or splits. The document is a formal press release/regulated information ('Informazione Regolamentata'), not just an announcement of a report (RPA/RNS).
2023-08-29 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.